DOC
Healthpeak PropertiesPrevious close
19.03
Change
+0.09 / +0.48%
P/E (TTM) ?
55.0
Market Cap
$13.5B
1M
−4.71%
S&P 500 −0.91% over same period
Volume / Avg Volume
6.5M / 5.6M
1.16× average
Latest earnings analysisFY2026 Q2Reported 2026-08-04
Healthpeak Q2 FY2026: revenue up 11.1%, FFO per share flat at $0.46
Healthpeak's second quarter of FY2026 reads Neutral: revenue grew 11.1% to $771.58 million and GAAP earnings beat the consensus estimate, but FFO as Adjusted per share was unchanged at $0.46. The catch is the data: the extracted revenue line, $216.46 million, is only the senior housing fee line, so read the segment table, not the headline field.
Read the full analysis →Revenue$0.22BYoY −68.80%
EPS (non-GAAP)$0.46Beatest. $0.03
Next-day move+0.79%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-08-04 | $216M | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-05-05 | $200M | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-02 | $604M | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-23 | $150M | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-24 | $149M | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-24 | $149M | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 55 of its 5-year rangeMid-range
5-year range 17.9 – 169.8 · Median 52.3
Last 4 quarters: $102M in buybacks + $846M in dividends, 7.00% of market cap combined
P/E (TTM)
55.0
P/B
1.7
P/S
4.5
Dividend Yield
8.16%
Earnings Reaction
Over the last 6 reports, the stock moved ±5.8% on average on the first trading day after, rising 3 times
Most recent +0.79%
Volatility & Correlation
1-year beta 0.37 · Correlation with S&P 500 0.16Low beta
Annualized volatility 29% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 0.22 | +45.4% | — | 0.05 | 0.08 |
| FY2026 Q1 | 0.20 | +34.5% | — | 0.19 | 0.28 |
| FY2025 Q4 | 0.16 | +6.7% | — | 0.11 | 0.16 |
| FY2025 Q3 | 0.15 | +5.3% | -94.0% | -0.12 | -0.17 |
| FY2025 Q2 | 0.15 | +5.7% | -85.5% | 0.03 | 0.05 |
| FY2025 Q1 | 0.15 | +7.3% | -83.4% | 0.04 | 0.06 |
| FY2024 Q4 | 0.15 | +7.1% | -89.8% | 0.00 | 0.02 |
| FY2024 Q3 | 0.14 | +6.8% | -96.2% | 0.09 | 0.12 |
| FY2024 Q2 | 0.14 | +8.2% | -94.4% | 0.15 | 0.21 |
| FY2024 Q1 | 0.14 | +9.2% | -75.6% | 0.01 | 0.01 |
| FY2023 Q4 | 0.14 | −74.0% | -64.6% | 0.07 | 0.13 |
| FY2023 Q3 | 0.13 | +9.6% | -73.9% | 0.06 | 0.12 |